Kang Yong Jung, Jeon Eun Su, Song Hae Young, Woo Jae Suk, Jung Jin Sup, Kim Yong Keun, Kim Jae Ho
Department of Physiology, Medical Research Institute, College of Medicine, Pusan National University, Busan 602-739, Republic of Korea.
J Cell Biochem. 2005 Aug 15;95(6):1135-45. doi: 10.1002/jcb.20499.
Platelet-derived growth factor (PDGF) is a critical regulator of proliferation and migration for mesenchymal type cells. In this study, we examined the role of mitogen-activated protein (MAP) kinases in the PDGF-BB-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells (hATSCs). The PDGF-induced proliferation was prevented by a pretreatment with the c-Jun N-terminal kinase (JNK) inhibitor, SP600125. However, it was not prevented by a pretreatment with a p38 MAP kinase inhibitor, SB202190, and a specific inhibitor of the upstream kinase of extracellular signal-regulated kinase (ERK1/2), U0126. Treatment with PDGF induced the activation of JNK and ERK in hATSCs, and pretreatment with SP600125 specifically inhibited the PDGF-induced activation of JNK. Treatment with PDGF induced the cell cycle transition from the G0/G1 phase to the S phase, the elevated expression of cyclin D1, and the phosphorylation of Rb, which were prevented by a pretreatment with SP600125. In addition, the PDGF-induced migration of hATSCs was completely blocked by a pretreatment with SP600125, but not with U0126 and SB202190. These results suggest that JNK protein kinase plays a key role in the PDGF-induced proliferation and migration of mesenchymal stem cells.
血小板衍生生长因子(PDGF)是间充质型细胞增殖和迁移的关键调节因子。在本研究中,我们检测了丝裂原活化蛋白(MAP)激酶在PDGF - BB诱导的人脂肪组织来源间充质干细胞(hATSCs)增殖和迁移中的作用。用c - Jun氨基末端激酶(JNK)抑制剂SP600125预处理可阻止PDGF诱导的增殖。然而,用p38 MAP激酶抑制剂SB202190和细胞外信号调节激酶(ERK1/2)上游激酶的特异性抑制剂U0126预处理并不能阻止这种增殖。用PDGF处理可诱导hATSCs中JNK和ERK的激活,用SP600125预处理可特异性抑制PDGF诱导的JNK激活。用PDGF处理可诱导细胞周期从G0/G1期过渡到S期,细胞周期蛋白D1表达升高以及Rb磷酸化,而用SP600125预处理可阻止这些变化。此外,用SP600125预处理可完全阻断PDGF诱导的hATSCs迁移,但U0126和SB202190则不能。这些结果表明,JNK蛋白激酶在PDGF诱导的间充质干细胞增殖和迁移中起关键作用。